Login
← Go Back
Natco Pharma
NATCOPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: V C Nannapaneni · MD: V C Nannapaneni · Listing date: Dec. 27, 1995 · Employees: 5046 · Hyderabad · http://www.natcopharma.co.in
Stock Price vs Company Growth
1d
0.9%
1w
3.3%
1m
6.1%
3m
18.7%
6m
28.3%
1y
82.6%
5y
15.2%
10y
21.2%
all
24.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,031 0.9%
827
1,107
Company Overview
Sales
3,828 Cr
Growth: 46.4%
Profit after Tax
1,278 Cr
Growth: 13.3%
Mid Cap
18,471 Cr
P/E: 14.6x
Industry P/E: 35.5x
Fundamentals
Sales (Cr) ₹ 3,828
Growth 46.4%
EBITDA 41.6%
P/S 4.8x
Dividend 1.1%
P/E 14.6x
Book Value ₹ 328
PEG Ratio 0.3x
ROE 23.5%
P/B 3.1x
Shareholding Pattern
Institutions
Qualified Institutional Buyers
6.25 %
Mirae Asset Emerging Bluechip Fund
4.06 %
Life Insurance Corporation Of India
2.46 %
Plenty Private Equity Fii I Limited
1.74 %
Nomura Singapore Limited
1.69 %
Promoters
V C Nannapaneni
12.39 %
Time Cap Pharma Labs Limited
9.42 %
Venkata Satya Swathi Kantamani
8.77 %
Natsoft Information Systems Pvt Ltd
8.65 %
Venkaiah Chowdary Nannapaneni Huf
2.98 %
Others
Increase    Decrease    No change
Company Profile Detailed
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.
Belongs to (21 Indices) view more
Investors (165)
ndl.infr...
sbi.magn...
alapati....
Followers (35)
nitin2
keerthi
deepak